---
title: "NRIX SEC Filings and Financial Statements | Tradytics"
description: "Annual income statements, balance sheets and cash flows for Nurix Therapeutics (NRIX), with links to the SEC filings."
url: "https://tradytics.com/research/NRIX/fundamentals"
image: "https://tradytics.com/api/v2/og/research.png?id=NRIX&v=stock-11994860"
---

# NRIX financial statements and SEC filings

## NRIX annual income statement

| Fiscal period end | Revenue | Operating income | Net income | SEC filing |
| --- | --- | --- | --- | --- |
| 2025-11-30 | $83.98M | -$285.67M | -$264.46M | [10-K](https://www.sec.gov/Archives/edgar/data/1549595/000154959526000016/0001549595-26-000016-index.htm) |
| 2024-11-30 | $54.55M | -$213.03M | -$193.57M | [10-K](https://www.sec.gov/Archives/edgar/data/1549595/000154959526000016/0001549595-26-000016-index.htm) |
| 2023-11-30 | $76.99M | -$155.06M | -$143.95M | [10-K](https://www.sec.gov/Archives/edgar/data/1549595/000154959526000016/0001549595-26-000016-index.htm) |
| 2022-11-30 | $38.63M | -$183.87M | -$180.36M | [10-K](https://www.sec.gov/Archives/edgar/data/1549595/000154959525000016/0001549595-25-000016-index.htm) |
| 2021-11-30 | $29.75M | -$117.89M | -$117.19M | [10-K](https://www.sec.gov/Archives/edgar/data/1549595/000154959523000021/0001549595-23-000021-index.htm) |
| 2020-11-30 | $17.82M | -$64.98M | -$43.24M | [10-K](https://www.sec.gov/Archives/edgar/data/1549595/000156459022003007/0001564590-22-003007-index.htm) |

## NRIX annual balance sheet

| Fiscal period end | Assets | Liabilities | Equity | SEC filing |
| --- | --- | --- | --- | --- |
| 2025-11-30 | $688.13M | $149.39M | $538.75M | [10-Q](https://www.sec.gov/Archives/edgar/data/1549595/000154959526000049/0001549595-26-000049-index.htm) |
| 2024-11-30 | $669.34M | $142.35M | $526.99M | [10-K](https://www.sec.gov/Archives/edgar/data/1549595/000154959526000016/0001549595-26-000016-index.htm) |
| 2023-11-30 | $355.60M | $155.10M | $200.49M | [10-K](https://www.sec.gov/Archives/edgar/data/1549595/000154959525000016/0001549595-25-000016-index.htm) |
| 2022-11-30 | $416.76M | $113.06M | $303.70M | [10-K](https://www.sec.gov/Archives/edgar/data/1549595/000154959524000025/0001549595-24-000025-index.htm) |
| 2021-11-30 | $476.77M | $134.47M | $342.30M | [10-K](https://www.sec.gov/Archives/edgar/data/1549595/000154959523000021/0001549595-23-000021-index.htm) |
| 2020-11-30 | $396.34M | $106.07M | $290.27M | [10-K](https://www.sec.gov/Archives/edgar/data/1549595/000156459022003007/0001564590-22-003007-index.htm) |

## NRIX annual cash flow

| Fiscal period end | Operating cash flow | Capital expenditure | Financing cash flow | SEC filing |
| --- | --- | --- | --- | --- |
| 2025-11-30 | -$249.47M | -$14.00M | $238.64M | [10-K](https://www.sec.gov/Archives/edgar/data/1549595/000154959526000016/0001549595-26-000016-index.htm) |
| 2024-11-30 | -$172.58M | -$9.27M | $485.67M | [10-K](https://www.sec.gov/Archives/edgar/data/1549595/000154959526000016/0001549595-26-000016-index.htm) |
| 2023-11-30 | -$81.36M | -$8.40M | $3.22M | [10-K](https://www.sec.gov/Archives/edgar/data/1549595/000154959526000016/0001549595-26-000016-index.htm) |
| 2022-11-30 | -$159.81M | -$12.24M | $117.19M | [10-K](https://www.sec.gov/Archives/edgar/data/1549595/000154959525000016/0001549595-25-000016-index.htm) |
| 2021-11-30 | -$84.36M | -$5.66M | $153.88M | [10-K](https://www.sec.gov/Archives/edgar/data/1549595/000154959523000021/0001549595-23-000021-index.htm) |
| 2020-11-30 | -$80.00K | -$4.55M | $339.02M | [10-K](https://www.sec.gov/Archives/edgar/data/1549595/000156459022003007/0001564590-22-003007-index.htm) |

- [NRIX stock research](https://tradytics.com/research/NRIX)
- [NRIX financial summary](https://tradytics.com/research/NRIX/financials)
- [Read the data without JavaScript](https://tradytics.com/research/NRIX/fundamentals?snapshot=1)
